bupropion has been researched along with cathinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Glennon, RA; Shalabi, AR; Walther, D | 1 |
| Krähenbühl, S; Liechti, ME; Luethi, D | 1 |
2 other study(ies) available for bupropion and cathinone
| Article | Year |
|---|---|
Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.
Topics: Alkaloids; Animals; Brain; Bupropion; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Neurotransmitter Agents; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley | 2017 |
Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.
Topics: Adenosine Triphosphate; Alkaloids; Benzodioxoles; Bupropion; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Hep G2 Cells; Hepatocytes; Humans; Lactic Acid; Membrane Potential, Mitochondrial; Methamphetamine; Mitochondria, Liver; Oxidative Phosphorylation; Oxidative Stress; Oxygen Consumption; Pentanones; Psychotropic Drugs; Pyrrolidines; Reactive Oxygen Species; Synthetic Cathinone | 2017 |